Gilead price target raised to $95 from $80 at Baird

Baird raised the firm’s price target on Gilead (GILD) to $95 from $80 and keeps a Neutral rating on the shares. The firm said its was another solid quarter and said the target increase was primarily driven by our expectation that the Sunlenca PrEP opportunity, and to some degree Livdelzi in PBC, has created some new commercial potential.